Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2003
12/18/2003WO2003103771A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103704A2 Proteins involved in the regulation of energy homeostasis
12/18/2003WO2003103676A2 Method of treating cancer using kinase inhibitors
12/18/2003WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003WO2003103593A2 Secretases related to alzheimer's dementia
12/18/2003WO2003103571A2 Flavivirus vaccines
12/18/2003WO2003103480A2 Gene cluster analysis for coronary artery disease
12/18/2003WO2003103478A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
12/18/2003WO2003103474A2 Diagnostic markers for disorders of the nervous system
12/18/2003WO2003085379A3 Microfluidic particle-analysis systems
12/18/2003WO2003078050A3 A building block forming a c-c bond upon reaction
12/18/2003WO2003074571A3 Cationic polyelectrolytes in biomolecule purification and analysis
12/18/2003WO2003074558A3 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
12/18/2003WO2003072814A3 Improved method for allele-specific pcr
12/18/2003WO2003067904A3 High-throughput cell identification and isolation method and apparatus
12/18/2003WO2003067263A3 Assay
12/18/2003WO2003067210A3 Methods and compositions for detecting the activation state of the multiple proteins in single cells
12/18/2003WO2003061520A3 Methods of modulating angiogenesis
12/18/2003WO2003058248A3 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
12/18/2003WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
12/18/2003WO2003057159A3 Psoriasin expression by breast epithelial cells
12/18/2003WO2003056031A3 Method and kit for detecting alkaline sphingomyelinase
12/18/2003WO2003054181A3 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants
12/18/2003WO2003054167A3 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
12/18/2003WO2003052141A9 High troughput analysis and detection of multiple target sequences using circular probes
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003046217A3 Universal dna chip, method for making same, and uses thereof
12/18/2003WO2003046179A3 G-protein coupled receptor lustr2 and uses thereof
12/18/2003WO2003042655A3 Diagnostic assay for antibiotic tolerance
12/18/2003WO2003042409A3 Germ line mutation in the promoter of e-caderine and diagnostic method for finding a greater susceptibility to gastric carcinoma
12/18/2003WO2003042407A3 Method for identifying therapeutic targets by use of genetic screens in drosophila melanogaster
12/18/2003WO2003040726A3 Screening for hepatitis c virus entry inhibitors
12/18/2003WO2003040687A3 Isolation and purification of nucleic acids
12/18/2003WO2003037164A3 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
12/18/2003WO2003036294A3 Articles of manufacture for detecting toxic substances
12/18/2003WO2003035893A3 Method for analyzing a nucleic acid
12/18/2003WO2003033437A3 A method of forming neuraminidase inhibitors by dynamic combinatorial chemistry and compounds obtained
12/18/2003WO2003031608A3 Mutated abl kinase domains
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003025627A3 Optical biosensor with enhanced activity retention for detection of halogenated organic compounds
12/18/2003WO2003025583A3 Differential diagnosis of disorders of iron metabolism
12/18/2003WO2003023057A3 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
12/18/2003WO2003020969A3 Method for marking l-nucleic acids
12/18/2003WO2003020896A9 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
12/18/2003WO2003018625A3 Allelic variants of herv-k18 provirus and their use in analysis
12/18/2003WO2003014377A3 Competitive binding assay for identifying inhibitors of hcv polymerase
12/18/2003WO2003014342A3 Identification of a dna variant associated with adult type hypolactasia
12/18/2003WO2003013536A3 Methods for treatment of cancer using irinotecan based on ugt1a1
12/18/2003WO2003002068A3 Diagnosis and treatment of cancer
12/18/2003WO2003000903A3 Regulation of human nek-like serine/threonine protein kinase
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2003000228A3 Method for high through put screening using a small scale mill or microfluidics
12/18/2003WO2002099421A3 Specific microarrays for breast cancer screening
12/18/2003WO2002099073A3 Method of assessing levels of infectious virus in a biological sample
12/18/2003WO2002097045A3 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/18/2003WO2002095059A3 Selection of target sites for antisense attack of rna
12/18/2003WO2002092850A3 Diagnostic method for osteoporosis and related disorders
12/18/2003WO2002092788A3 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
12/18/2003WO2002092767A3 DETECTION OF GD2 SYNTHASE mRNA AND USES THEREOF
12/18/2003WO2002090543A3 Regulation of human phosphatidic acid phosphatase type 2c-like protein
12/18/2003WO2002086446A3 Compositions and methods for gender sorting
12/18/2003WO2002084567A3 Method for analyzing t lymphocytes with the aid of t lymphocyte receptors of an organism
12/18/2003WO2002082087A3 Diagnosis and treatment of enterococcus faecium related disease
12/18/2003WO2002081652A3 Use of yacm and yqej, essential bacterial genes and polypeptides and their use
12/18/2003WO2002081627A3 Methods of screening and using inhibitors of angiogenesis
12/18/2003WO2002079486A3 Milieux de detection specific de staphylococcus aureus
12/18/2003WO2002074157A3 A mammalian immortalized liver cell
12/18/2003WO2002072773A3 Methods and compositions for amplification of rna sequences
12/18/2003WO2002066504A3 Protein-protein interactions in saccharomyces cerevisiae
12/18/2003WO2002064842A3 Quantitative epstein barr virus pcr rapid assay
12/18/2003WO2002062960A3 Cell fusion assays for the identification of antiviral compounds, and systems and kits for practicing the same
12/18/2003WO2002059378A3 Methods and compositions for identifying gene function
12/18/2003WO2002059371B1 Genome-wide location and function of dna binding proteins
12/18/2003WO2002057492A9 Methods and compositions for detecting polynucleotide duplex damage
12/18/2003WO2002054072A3 Assay to determine efficacy of treatment for mycobacterial infection
12/18/2003WO2002053778A3 Method for relative quantification of attached nucleic acids
12/18/2003WO2002040720A8 Compositions and methods relating to ovary specific genes and proteins
12/18/2003WO2002036805A3 Scar test for the authentication of chinese medicinal materials
12/18/2003WO2002020824A3 Process for estimating random error in chemical and biological assays
12/18/2003WO2002014536A9 Odulating multiple lineage kinase proteins
12/18/2003WO2000065025A3 Dna molecules encoding human endothelin converting enzyme 3
12/18/2003US20030233681 ICE1, a regulator of cold induced transcriptome and freezing tolerance in plants
12/18/2003US20030233124 Methods of treating disorders by altering ion flux across cell membranes with electric fields
12/18/2003US20030232979 Nucleic acid labeling compounds
12/18/2003US20030232975 Comprises nucleotide sequences coding polypeptides for diagnosing, preventing and treating cancer
12/18/2003US20030232801 Identification of compounds for the treatment or prevention of proliferative diseases
12/18/2003US20030232791 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
12/18/2003US20030232752 Proliferated cell lines and uses thereof
12/18/2003US20030232750 Indolicidin peptide analogues containing at least two basic amino acids; bactericide
12/18/2003US20030232749 Methods for SHP1 mediated neuroprotection
12/18/2003US20030232747 Method of identifying a pharmaceutically active compound for the treatment of a condition caused by altered expression of the insulin receptor
12/18/2003US20030232440 Antisense modulation of STAT1 expression
12/18/2003US20030232418 Comprises pyrroloquinoline quinone dependent glucose dehydrogenase (PQQGDH) having decreased activity on disaccharides; measurement of glucose in blood sample; food analysis
12/18/2003US20030232416 Synthesis of synthons for the manufacture of bioactive compounds
12/18/2003US20030232405 Producing fluorescence from fluorogenic acridine substrates reactive with a peroxidase enzyme; use in assays for peroxidase enzymes
12/18/2003US20030232404 Comprises heat resistant beetle luciferase with increased half-life for use as diagnostic tool in genetic engineering
12/18/2003US20030232403 Devices and methods for the performance of miniaturized homogeneous assays
12/18/2003US20030232402 Peptide nucleic acids for detecting bacteria in air, food, beverages, water, pharmaceutical, personal care, dairy, mail and/or packaging product
12/18/2003US20030232401 Measuring the bacteria content of fluids; high throughput assay